Operating cash flow swung from a $32.2M outflow in 2026Q1 to a $2.2M inflow in 2026Q3, with free cash flow of only 1.7% of revenue suggesting cash conversion depends heavily on working capital timing.
Ardelyx, Inc. (ARDX) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Cash from Operations | -15.51M | -42.48M | -44.81M | -89.72M | -70.04M | -152.55M | -81.44M | -76.48M | -70.27M | -65.19M | -92.53M | -71.84M | 13.4M | 1.81M | 21.98M |
| Operating CF Margin % | - | -10.43% | -13.43% | -72.09% | -134.29% | -1510.85% | -1075.62% | -1448.29% | -2695.59% | -155.21% | -385.14% | -299.01% | 42.36% | 6.26% | 406.28% |
| Operating CF Growth % | 699.29% | 5.19% | 50.06% | -28.09% | 54.08% | -87.33% | -6.47% | -8.84% | -7.8% | 29.55% | -28.81% | -636.24% | 639.76% | -91.76% | - |
| Net Income | -55.47M | -61.6M | -39.14M | -66.07M | -67.21M | -158.16M | -94.31M | -94.94M | -91.3M | -64.34M | -112.39M | -29.62M | -3.21M | -6.56M | -9.79M |
| Depreciation & Amortization | 3.06M | 3.06M | 2.06M | 1.29M | 1.14M | 2.81M | 2.54M | 2.5M | 2.68M | 2.64M | 1.29M | 829K | 302K | 592K | 675K |
| Stock-Based Compensation | 57.02M | 48.96M | 37.38M | 13.53M | 10.75M | 12.04M | 10.58M | 9.94M | 9.23M | 9.59M | 5.32M | 2.63M | 1.69M | 352K | 473K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -190K | 315K | -262K | -1.02M | 11K | -86K | 65K | 0 | 0 | 0 |
| Other Non-Cash Items | 2.6M | -1.55M | 4.05M | 4.91M | 4.84M | 2.88M | 2.65M | 3.3M | 792K | 567K | 540K | 458K | 1.59M | 3.51M | 950K |
| Working Capital Changes | -22.72M | -31.35M | -49.17M | -43.39M | -19.57M | -11.92M | -3.21M | 2.98M | 9.35M | -13.66M | 12.79M | -46.2M | 13.02M | 3.92M | 29.67M |
| Change in Receivables | -16.83M | -14.14M | -35.67M | -14.3M | -7.23M | -502K | 750K | 85K | 10.71M | -10.8M | 0 | 2.58M | 3.85M | -3.36M | -3.07M |
| Change in Inventory | -28.2M | -31.92M | -41.7M | -21.14M | -28.35M | -10.37M | -750K | -3.41M | 1.88M | -1.9M | 0 | -2.08M | 743K | -730K | -578K |
| Change in Payables | 15.27M | 3.23M | 4.86M | 279K | 6.58M | -1.35M | 3.44M | 39K | -2.73M | -1.03M | 2.15M | -371K | 831K | 1.14M | -105K |
| Cash from Investing | -37.56M | -8.96M | -18.32M | -131.25M | 18.41M | 50.95M | -31.44M | 23.37M | -29.89M | 65.29M | -131.08M | -3.45M | -1.86M | -278K | -128K |
| Capital Expenditures | -443K | -1.49M | -1.01M | -344K | -55K | -1.87M | -324K | -325K | -311K | -2.35M | -4.87M | -3.45M | -1.86M | -278K | -128K |
| CapEx % of Revenue | 0.09% | 0.37% | 0.3% | 0.28% | 0.11% | 18.49% | 4.28% | 6.15% | 11.93% | 5.61% | 20.25% | 14.38% | 5.87% | 0.96% | 2.37% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -52.81M | 31.44M | -23.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 1.8M | 52.81M | -31.44M | 23.7M | -29.58M | 67.64M | -126.21M | 0 | 0 | 0 | 0 |
| Cash from Financing | 56.68M | 54.51M | 106.59M | 146.29M | 75.34M | 83M | 22.78M | 155.48M | 103.55M | 685K | 191.2M | 75.01M | 61.31M | -1K | 270K |
| Debt Issued (Net) | 48.04M | 48.67M | 99.45M | 22.39M | -6.07M | -19.44M | -125K | 0 | 49.29M | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 8.64M | 5.84M | 8.14M | 119.24M | 71.63M | 101.15M | 21.05M | 154.9M | 53.77M | 0 | 190.57M | 74.32M | 61.24M | -1K | -20K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2K | -2K | -20K |
| Other Financing | 0 | 0 | -1M | 4.67M | 9.78M | 1.3M | 1.85M | 574K | 491K | 685K | 631K | 689K | 69K | 0 | 290K |
| Net Change in Cash | 3.6M | 3.07M | 43.46M | -74.67M | 23.71M | -18.6M | -90.1M | 102.36M | 3.38M | 785K | -32.41M | -282K | 72.85M | 1.53M | 22.12M |
| Free Cash Flow | -15.96M | -43.98M | -45.82M | -90.06M | -70.1M | -154.42M | -81.76M | -76.81M | -70.58M | -67.55M | -97.4M | -75.29M | 11.54M | 1.53M | 21.85M |
| FCF Margin % | -3.41% | -10.8% | -13.73% | -72.36% | -134.4% | -1529.35% | -1079.9% | -1454.44% | -2707.52% | -160.82% | -405.39% | -313.39% | 36.5% | 5.3% | 403.92% |
| FCF Growth % | 71.17% | 4.03% | 49.12% | -28.48% | 54.6% | -88.87% | -6.44% | -8.82% | -4.5% | 30.65% | -29.36% | -752.4% | 652.84% | -92.98% | - |
| FCF per Share | -0.06 | -0.18 | -0.19 | -0.41 | -0.44 | -1.48 | -0.91 | -1.19 | -1.26 | -1.42 | -2.43 | -3.29 | 0.62 | 0.11 | 1.64 |
| FCF Conversion (FCF/Net Income) | 0.29x | 0.69x | 1.14x | 1.36x | 1.04x | 0.96x | 0.86x | 0.81x | 0.77x | 1.01x | 0.82x | 2.43x | -4.17x | -0.28x | -2.25x |
| Interest Paid | 12.61M | 15.72M | 11.41M | 4.24M | 2.9M | 3.47M | 4.2M | 4.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 95K | 485K | 266K | 51K | 6K | 4K | 1K | 2K | 4K | 3K | 0 | 69K | 0 | 160K | 0 |
Quick answers to the most common questions about buying ARDX stock.
Ardelyx, Inc. (ARDX) generated $-42.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Ardelyx, Inc. (ARDX) reported negative free cash flow of $44.0M in 2025, indicating capital requirements exceeded cash from operations.
Ardelyx, Inc. (ARDX) spent $1.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
Key Metrics
Top Statement Risk
Quarterly cash burn and dilution
Metrics are mathematically derived from official filings.
Operating Cash Flow Lags Reported Earnings
Based on reported quarterly figures, Ardelyx's operating cash flow swung from a $32.2M outflow in 2026Q1 to a $2.2M inflow in 2026Q3, while net income remained negative in most periods, indicating cash conversion depends heavily on working capital timing rather than earnings.
The relationship between net income and operating cash flow is erratic, with the OCF-to-net-income ratio flipping sign across quarters, which makes the ratio itself uninformative. Non-cash items such as stock-based compensation of roughly $10M to $15M per quarter and depreciation near $0.5M to $0.9M are a meaningful portion of the gap, suggesting that a substantial share of reported losses is non-cash. Investors should monitor whether operating cash flow turns positive on a sustained basis rather than in isolated quarters.
Free Cash Flow Turns Positive Only Intermittently
According to the reported cash flow statements, Ardelyx's free cash flow reached $20.6M in 2025Q4 but fell to negative $32.3M in 2026Q1, with positive FCF appearing in only a minority of the ten quarters analyzed.
Free cash flow margins ranged from roughly -52% to +16% across the period, indicating that the business has not yet established a stable cash-generating profile. Capital expenditure is minimal, with CapEx to revenue below 1% in every quarter, so the FCF volatility is driven almost entirely by operating cash flow and working capital swings. This pattern suggests the path to self-funding remains dependent on operating consistency that has yet to be demonstrated.
Working Capital Swings Drive Quarterly Results
As reported in the quarterly statements, Ardelyx's working capital change ranged from a $13.7M outflow in 2026Q3 to a $7.7M inflow in 2025Q4, with several quarters showing outflows of $9M to $19M that absorbed a large share of operating results.
The magnitude of working capital movements relative to operating cash flow suggests receivable collection and channel inventory timing are material to reported cash generation. Gross-to-net adjustments and wholesaler inventory levels can shift cash timing without changing underlying patient demand, so the inflow in 2025Q4 may not be repeatable. Investors should monitor receivables and inventory trends to judge whether the working capital drag is structural or seasonal.
Cash Preservation Over Shareholder Returns
Based on reported figures, Ardelyx paid no dividends and executed no share repurchases or acquisitions across the ten quarters, with capital deployment confined to operations and minimal capital expenditure.
The absence of shareholder distributions is consistent with a company still funding commercialization rather than returning capital. The reported absence of debt paydown or acquisition activity in the cash flow data means the cash position of roughly $68M is being preserved for operations. Given recurring operating cash outflows in several quarters, the balance may warrant further investigation regarding the timeline for potential external financing.
Cumulative Losses Outweigh Cash Generation
According to the ten-quarter data, cumulative net income was deeply negative, with losses of roughly $41M in 2025Q1 and $37.6M in 2026Q1 alone, while cumulative operating cash flow was also negative across the period.
The cumulative gap between reported earnings and cash reality is less pronounced than the single-quarter swings suggest, because stock-based compensation accounts for a large non-cash add-back each quarter. Still, the net cash position across the sample remains negative, indicating the business has consumed rather than generated cash over this window. Investors should monitor whether cumulative operating cash flow turns durably positive before drawing conclusions about earnings quality.
Stock Compensation May Mask Burn
Based on reported figures, stock-based compensation of roughly $10M to $15M per quarter means a meaningful share of Ardelyx's cash-flow picture depends on non-cash add-backs that do not appear in operating cash outflows.
Adding back stock-based compensation can make operating results look less negative than the economic cost of paying staff, since dilution from equity awards transfers value to shareholders over time. The apparent improvement in the 2026Q3 operating cash flow of $2.2M should therefore be read alongside share count changes and the continued need for external capital. Investors should monitor whether operating cash flow remains positive once stock compensation is treated as a real expense.